ALNY is in a strong downtrend
-66
BearishSidewaysBullish
Why this reading
- Price is below its 50-day average ($237.78).
- Price is below its 200-day average ($286.46).
- 50-day average is below the 200-day (long-term structure is down).
- MACD momentum is weakening and the MACD line is below zero.
- RSI 24 — weak momentum, in oversold territory.
- The 50-day average is flat.
- Recent swings show higher highs and higher lows.
Price chart
Lower pane: RSI (14) with 70 and 30 marked. Arrows mark candlestick patterns.
Indicators
| Indicator | Value | Reading | What it means |
|---|---|---|---|
| Moving averages | Bearish stack | Bearish | 20-day $224.39, 50-day $237.78, 200-day $286.46 |
| RSI (14) | 24.0 | Bullish | Oversold — selling may be exhausted; watch for a bounce. |
| MACD (12,26,9) | -2.72 | Bearish | MACD is below its signal line. |
| Bollinger %B | -0.53 | Bearish | Closing below the lower band — strong selling, but stretched. |
| Volatility (ATR 14) | $11.70 (6.7%) | Neutral | High daily volatility — expect large swings. |
| Volume vs 20d avg | 6.86× | Neutral | Unusually heavy volume — the latest move has conviction. |
| 52-week range | 0% | Bearish | Low $172.41, high $482.50 |
Key levels
- $306.55Resistance, 3 touches+76.3%
- $285.87Resistance, 4 touches+64.4%
- $236.55Resistance, 3 touches+36.0%
- $173.89Last close
Recent candlestick patterns
- Bearish EngulfingBearish
A strong down candle fully covers the prior up candle's body after an advance.
- Inverted HammerBullish
Long upper wick after a decline — an early sign buyers are testing higher prices.
- Three Black CrowsBearish
Three consecutive strong down candles, each closing lower — steady selling pressure.
Latest news
- Alnylam Pharmaceuticals Reports Q3 2026 Financial Resultsfiscal.ai
- Alnylam Updates Phase 3 TRITON-CM Study for Nucresiranfiscal.ai
- 12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga
- Alphabet Sinks 11.8%, Small Caps Rally on Strong GDP Growth: Stock Market Todaybenzinga
- Alnylam Pharmaceuticals Q3 2026 Earnings Call Transcriptbenzinga